The Rising Cost of Insulin for Pump Users: How Policy Drives Prices

Brown-Georgi, Julia; Chhabra, Harmeet; Vigersky, Robert A.

doi:10.1177/1932296820947100

Cited by 4 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The cost of the pump is not only limited to the device but also running costs for accessories, cartridge syringes, batteries, skin preparation items, cannulas, and infusion sets, which are significantly higher than the regular insulin pens and syringes. Because insulin is a lifesaving essential medicine, every effort should be made to minimize the cost to the patient and his family[ 115 ].…”

Section: Disadvantages Of Insulin Pump Therapymentioning

confidence: 99%

Insulin pumps in children - a systematic review

Al‐Biltagi¹,

Saeed²,

Bediwy³

et al. 2022

World J Clin Pediatr

View full text Add to dashboard Cite

BACKGROUND Insulin pump therapy is a real breakthrough in managing diabetes Mellitus, particularly in children. It can deliver a tiny amount of insulin and decreases the need for frequent needle injections. It also helps to maintain adequate and optimal glycemic control to reduce the risk of metabolic derangements in different tissues. Children are suitable candidates for pump therapy as they need a more freestyle and proper metabolic control to ensure adequate growth and development. Therefore, children and their caregivers should have proper education and training and understand the proper use of insulin pumps to achieve successful pump therapy. The pump therapy continuously improves to enhance its performance and increase its simulation of the human pancreas. Nonetheless, there is yet a long way to reach the desired goal. AIM To review discusses the history of pump development, its indications, types, proper use, special conditions that may enface the children and their families while using the pump, its general care, and its advantages and disadvantages. METHODS We conducted comprehensive literature searches of electronic databases until June 30, 2022, related to pump therapy in children and published in the English language. RESULTS We included 118 articles concerned with insulin pumps, 61 were reviews, systemic reviews, and meta-analyses, 47 were primary research studies with strong design, and ten were guidelines. CONCLUSION The insulin pump provides fewer needles and can provide very tiny insulin doses, a convenient and more flexible way to modify the needed insulin physiologically, like the human pancreas, and can offer adequate and optimal glycemic control to reduce the risk of metabolic derangements in different tissues.

show abstract

Section: Disadvantages Of Insulin Pump Therapymentioning

confidence: 99%

Insulin pumps in children - a systematic review

Al‐Biltagi¹,

Saeed²,

Bediwy³

et al. 2022

World J Clin Pediatr

View full text Add to dashboard Cite

show abstract

“…There are concerns related to access to insulin for people living with T1DM [ 18 ] in countries with limited government expenditures for health because they must pay out-of-pocket for all or part of their diabetes care, including insulin and syringes, blood glucose meters, delivery devices, and necessary health education [ 19 , 20 ]. Some patients reported on specific questionnaires cost-related underuse of insulin or cost-related change in insulin type, a scenario caused by low personal income.…”

Section: Introductionmentioning

confidence: 99%

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review

Elian,

Popovici,

Ozon

et al. 2023

Life

View full text Add to dashboard Cite

Type 1 diabetes mellitus is a chronic autoimmune disease that affects millions of people and generates high healthcare costs due to frequent complications when inappropriately managed. Our paper aimed to review the latest technologies used in T1DM management for better glycemic control and their impact on daily life for people with diabetes. Continuous glucose monitoring systems provide a better understanding of daily glycemic variations for children and adults and can be easily used. These systems diminish diabetes distress and improve diabetes control by decreasing hypoglycemia. Continuous subcutaneous insulin infusions have proven their benefits in selected patients. There is a tendency to use more complex systems, such as hybrid closed-loop systems that can modulate insulin infusion based on glycemic readings and artificial intelligence-based algorithms. It can help people manage the burdens associated with T1DM management, such as fear of hypoglycemia, exercising, and long-term complications. The future is promising and aims to develop more complex ways of automated control of glycemic levels to diminish the distress of individuals living with diabetes.

show abstract

“…There are concerns related to access to insulin for people living with T1DM [18] in countries with limited government expenditures for health because they must pay out-of pocket for all or part of their diabetes care, including insulin and syringes, blood glucose meters, delivery devices, and necessary health education [19,20]. Some patients reported on specific questionnaires cost-related underuse of insulin or cost-related change in insu lin type, a scenario caused by low personal income.…”

Section: Introductionmentioning

confidence: 99%

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life - A State-of-Art Review

Elian¹,

Popovici²,

Ozon³

et al. 2023

Preprint

View full text Add to dashboard Cite

Type 1 Diabetes mellitus (T1DM) occurs when insulin is not produced in the Pancreas due to the autoimmune destruction of the beta cells. The patients may be diagnosed after 80-90% of the beta cells are destroyed. Insulin remains the essential medicine in T1DM management, under continuous monitoring of glucose levels. T1DM management consists of a complex and precise set of self-care measures for the entire life; during this continuous process, the patients could become overwhelmed, angry, anxious, frustrated, and/or discouraged. Therefore, to be widely used and provide general benefits, new technologies for DM management must provide clinical advantages without compromising safety. The compliance of T1DM patients is also essential, thus improving their quality of life (QoL). Moreover, the accessibility of the new system for patients through healthcare coverage is critical; they must be able to buy the new devices and accessories and pay for their maintenance. In this context, our work aims to describe the most recent technologies regarding continuous glucose monitors (CGMs) and continuous subcutaneous insulin infusion (CSII) systems, correlated with psychosocial impact and capacity to improve T1DM patients' life quality.

show abstract

The Rising Cost of Insulin for Pump Users: How Policy Drives Prices

Cited by 4 publications

References 5 publications

Insulin pumps in children - a systematic review

Insulin pumps in children - a systematic review

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life - A State-of-Art Review

Contact Info

Product

Resources

About